Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
BioMarin revenue
BioMarin's revenue is $2.9 billion.
What is BioMarin's revenue?
- BioMarin's revenue growth from 2003 to 2024 is 23,486.07%.
- BioMarin has 2,581 employees, and the revenue per employee ratio is $1,105,740.
- BioMarin's peak quarterly revenue was $747.3M in 2024(q4).
- BioMarin peak revenue was $2.9B in 2024.
- BioMarin annual revenue for 2023 was 2.4B, 15.42% growth from 2022.
- BioMarin annual revenue for 2024 was 2.9B, 17.97% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
BioMarin historical revenue
BioMarin's peak revenue was $2.9B in 2024. The peak quarterly revenue was $747.3M in 2024(q4).
BioMarin's revenue increased from $12.1m in 2003 to $2.9B currently. That's a 23,486.07% change in annual revenue.
BioMarin annual revenue
BioMarin annual revenue over time
| Fiscal year / year | BioMarin revenue |
|---|---|
| 2009 | $324.7M |
| 2010 | $376.3M |
| 2011 | $441.4M |
| 2012 | $500.7M |
| 2013 | $548.5M |
| 2014 | $749.3M |
| 2015 | $889.9M |
| 2016 | $1.1B |
| 2017 | $1.3B |
| 2018 | $1.5B |
| 2019 | $1.7B |
| 2020 | $1.9B |
| 2021 | $1.8B |
| 2022 | $2.1B |
| 2023 | $2.4B |
| 2024 | $2.9B |
Rate BioMarin's financial transparency
BioMarin annual growth
BioMarin saw the greatest revenue growth in 2006, when revenue increased by 228.06%.
BioMarin had the lowest revenue growth in 2021, when revenue changed by -0.76%.
BioMarin annual growth rate over time
| Year | BioMarin growth |
|---|---|
| 2009 | 9%↑ |
| 2010 | 16%↑ |
| 2011 | 17%↑ |
| 2012 | 13%↑ |
| 2013 | 10%↑ |
| 2014 | 37%↑ |
| 2015 | 19%↑ |
| 2016 | 26%↑ |
| 2017 | 18%↑ |
| 2018 | 14%↑ |
| 2019 | 14%↑ |
| 2020 | 9%↑ |
| 2021 | -1%↓ |
| 2022 | 14%↑ |
| 2023 | 15%↑ |
| 2024 | 18%↑ |
BioMarin quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
BioMarin quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $74.0M | $82.8M | $80.8M | $87.1M |
| 2010 | $85.0M | $92.0M | $97.8M | $101.6M |
| 2011 | $109.5M | $110.6M | $113.4M | $107.8M |
| 2012 | $116.6M | $124.0M | $128.1M | $131.9M |
| 2013 | $127.9M | $136.8M | $136.9M | $146.9M |
| 2014 | $151.6M | $191.8M | $176.5M | $230.1M |
| 2015 | $202.9M | $250.1M | $208.9M | $227.9M |
| 2016 | $236.7M | $300.1M | $279.9M | $300.1M |
| 2017 | $303.7M | $317.4M | $334.1M | $358.3M |
| 2018 | $373.4M | $372.8M | $391.7M | $353.2M |
| 2019 | $400.7M | $387.8M | $461.1M | $454.4M |
| 2020 | $502.1M | $429.5M | $476.8M | $452.1M |
| 2021 | $486.0M | $501.7M | $408.7M | $449.8M |
| 2022 | $519.4M | $533.8M | $505.3M | $537.5M |
| 2023 | $596.4M | $595.3M | $581.3M | $646.2M |
| 2024 | $648.8M | $712.0M | $745.7M | $747.3M |
BioMarin jobs nearby
Do you work at BioMarin?
Is BioMarin transparent about its revenue structure?
BioMarin financial information
| CEO | Jean Jacques Bienaime |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 2,581 |
| Date Founded | 1997 |
| Headquarters | San Rafael, California |
| Number of Locations | 4 |
| Revenue | $2.9B |
| Net Income | $141,561,000 |
| Gross Proft | $2.3B (2024) |
| EBITDA | $522.8M (2024) |
| PE Ratio | 40.06 |
| Tax Rate | 0.2% |
| Market Capitalization | $17.1B |
| Total Assets | $6,375,074,000 |
| Ticker | BMRN |
BioMarin jobs you might like
BioMarin financing
BioMarin received early financing of $585.8M on 2020-05-11.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $585.8M | 05/2020 |
BioMarin competitors
BioMarin's top competitor, Abbott, earned an annual revenue of $42.0B.
BioMarin's smallest competitor is Sequoia Consulting Group, Llc with revenue of $1.3M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Abbott | $73,973 | $42.0B | 109,000 | 1,661 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 291 |
| Genentech | $97,473 | $166.9M | 13,638 | 526 |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| Regeneron | $85,589 | $14.2B | 9,123 | 326 |
| PDL BioPharma | $48,962 | $30.7M | 75 | - |
| Illumina | $94,044 | $4.4B | 7,800 | 123 |
| Medimmune | $78,540 | $422.2M | 6,030 | - |
| Insmed | $81,784 | $363.7M | 373 | 71 |
| Amicus Therapeutics | $88,124 | $528.3M | 508 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
BioMarin highest paying jobs
Zippia gives an in-depth look into the details of BioMarin, including salaries, political affiliations, employee data, and more, in order to inform job seekers about BioMarin. The employee data is based on information from people who have self-reported their past or current employments at BioMarin. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by BioMarin. The data presented on this page does not represent the view of BioMarin and its employees or that of Zippia.
BioMarin may also be known as or be related to BioMarin, BioMarin Pharmaceutical, BioMarin Pharmaceutical Inc, BioMarin Pharmaceutical Inc., Biomarin Pharmaceutical Inc. and biomarin.